Clinical Advisory Board
Robert C. Moellering, Jr., M.D.
Shields Warren-Mallinckrodt Professor of Medical Research
Harvard Medical School
Dr. Robert Moellering is the Shields Warren-Mallinckrodt Professor of Medical Research at Harvard Medical School. He served as Physician-in-Chief at the New England Deaconess Hospital from 1981 until 1996. He subsequently served as the Herrman L. Blumgart Professor of Medicine at Harvard Medical School, and Physician-in-Chief and Chairman of the Department of Medicine at the Beth Israel Deaconess Medical Center (BIDMC) in Boston through 2005. During that period he was also President and CEO of Harvard Medical Faculty Physicians at BIDMC.
Trained as an infectious diseases specialist, Dr. Moellering has been actively involved in laboratory research for the past 35 years carrying out numerous studies of the mechanism of action and mechanisms of resistance to antimicrobial agents and his work is reported in over 400 publications in scientific journals. He is a Fellow of the Infectious Diseases Society of America, Master of the American College of Physicians, an Honorary Fellow of the Royal College of Physicians, and has been elected to membership in the American Society for Clinical Investigation and the Association of American Physicians. He is Editor-in-Chief Emeritus of Antimicrobial Agents and Chemotherapy, Editor of Infectious Disease Clinics of North America, and Associate Editor of the Journal of Infection and Public Health.
Dr. Moellering has received many prestigious awards, including honorary doctorate degrees from Valparaiso University and St. Elizabeth University (Bratislava), the Garrod Medal from the British Society for Antimicrobial Chemotherapy, the Feldman Award and the Maxwell Finland Award from the Infectious Diseases Society of America, the Hoechst-Roussel Award from the American Academy for Microbiology, and in 2006 the Maxwell Finland Award for Scientific Achievement from the National Foundation for Infectious Diseases. More recently, he is the 2008 recipient of the Alexander Fleming Award for Lifetime Achievement from the Infectious Diseases Society of America and the 2009 recipient of the Yen Memorial Award from the International Society for Chemotherapy.
Jeffrey S. Groeger, MD
Chief, Urgent Care Service
Memorial Sloan Kettering Cancer Center
Dr. Groeger is the Chief of the Urgent Care Service of the Department of Medicine at Memorial Hospital for Cancer and Allied Diseases, New York, New York. He is an Attending Critical Care Physician, Member of Memorial Sloan-Kettering Cancer Center and Professor of Clinical Medicine at the Weill College of Medicine of Cornell University.
Dr. Groeger's expertise is in the management of the critically ill immunocompromised patient. His publications on this topic include over 60 peer-reviewed papers and greater than 100 abstracts, book chapters, books and invited articles.
Dr. Groeger attended medical school at the University of Cincinnati College of Medicine, graduating in 1977. After completing his residency in Internal Medicine at Lenox Hill Hospital he completed fellowship training in Critical Care Medicine at Memorial Sloan-Kettering Cancer Center. He was Medical Director of the Special Care Unit at Memorial Sloan-Kettering until 2003 when he assumed his current position.
Peter G. Pappas, M.D.
President, Mycoses Study Group
Professor of Medicine, University of Alabama
Dr. Pappas is a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at the University of Alabama in Birmingham. Following completion of his fellowship, he was on the clinical faculty at the University of North Carolina School of Medicine in Chapel Hill, NC, through its affiliated hospital in Wilmington, North Carolina. In 1988, he joined the faculty at the University of Alabama in Birmingham School of Medicine, with a focus on infections in immunocompromised hosts, with a specific focus on the invasive mycoses. His main areas of research interest have included the development of new therapies for fungal infections and understanding the epidemiology of candidiasis, the endemic mycoses, and cryptococcosis. He has led a number of randomized clinical trials in candidiasis, cryptococcosis, aspergillosis, sporotrichosis, blastomycosis, and histoplasmosis. He is currently the Principal Investigator for the MSG, a clinical trials group that performs international multicenter trials, creates treatment guidelines for invasive mycoses, describes the evolving epidemiology of fungal infections, and explores newer diagnostic modalities for the more common mycoses. He is also PI of the Organ Transplant Infection Detection and Prevention Program (OTIP), a collaborative multicenter group funded by CDC to explore the risk factors and epidemiology of transplant associated infections. Dr. Pappas has published more than 130 peer-reviewed manuscripts, over 50 chapters, over 130 abstracts for scientific meetings, and has co-authored 6 books.
Dr. Pappas attended medical school at the University of Alabama School of Medicine,graduating in 1978. He completed his residency in internal medicine, chief medical residency and infectious diseases fellowship at the University of Washington in Seattle.
Louis B. Rice, MD
Chair of the Department of Medicine at The Warren Alpert Medical School of Brown University
Chief of Medicine at Rhode Island Hospital and The Miriam Hospital
Louis B. Rice, MD is the Chairman of Medicine and Joukowsky Family Professor of Medicine at the Warren Alpert Medical School of Brown University and Physician-in-Chief of Medicine at Rhode Island Hospital and The Miriam Hospital in Providence, RI. He also serves as the Executive Physician-in-Chief of Medicine at Memorial Hospital of Rhode Island, the Providence Veterans Administration Medical Center and Women & Infants Hospital. Dr. Rice is also the President of University Medicine, Inc. a non-profit, academic, multi-specialty medical group with practice in Providence, RI and its surrounding communities.
Dr. Rice previously served as Professor of Medicine at Case Western Reserve University in Ohio and as Chief of Medical Service at the Cleveland VA Medical Center as well as Vice Chairman of the Department of Medicine at the University Hospitals of Cleveland. He is a member of the American Society for Microbiology (ASM) and Editor-in-Chief of the ASM journal, Antimicrobial Agents and Chemotherapy; the Infectious Disease Society of America, where he currently chairs the research committee and the research on resistance working group; and is a fellow of the American College of Physicians.
Dr. Rice received his undergraduate degree from Harvard University and his medical degree from Columbia University College of Physicians and Surgeons. He completed his internship and residency in medicine at New York University Medical Center. He also completed clinical and research fellowships in infectious diseases at the former New England Deaconess Medical Center and Harvard Medical School.
He served as the Chair of the National Institutes of Health study section on drug discovery and mechanisms of antimicrobial resistance and for 10 years as associate editor of Antimicrobial Agents and Chemotherapy; was the Inpatient Teacher of the Year at University Hospitals and Cleveland VA Medical Center; received the Kaiser-Permanente Award for Teaching Excellence; served as the keynote speaker as the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy and delivered the Maxwell Finland Lecture at the National Meeting of the Infectious Diseases Society of America in 2007.
Dr. Rice is an international authority on antimicrobial resistance in bacteria. His research interests include understanding the mechanisms of antibiotic resistance in bacteria; preventing hospital infections; and developing antibiotic usage strategies that will minimize the emergence and spread of antibiotic resistance.
Eric Rosenberg, MD
Co-Director, Clinical Microbiology Laboratories
Massachusetts General Hospital, Harvard Medical School
Dr. Eric Rosenberg is an Associate Professor of Medicine at the Massachusetts General Hospital and Harvard Medical School. He is an Infectious disease clinician and the Co-Director of the Clinical Microbiology laboratories at the MGH with a focus on molecular diagnostics and diagnostic testing in immunocompromised hosts. Dr. Rosenberg is also the Associate Editor for the Case Records of the MGH, published weekly in the New England Journal of Medicine. His research focuses on the immunology and pathogenesis of HIV infection with a particular interest in CD4+ T helper cells in persons with acute HIV and long-term non-progressive infection. In addition, he has been studying the impact highly active antiretroviral therapy during the acute stages of HIV infection and the prospects for supervised treatment interruption in the individuals.